"Designing Growth Strategies is in our DNA"

Viral Vaccines Market Size, Share & COVID-19 Impact Analysis, By Form (Liquid and Lyophilized), By Container Format (Vials and Prefilled Syringes), By Biosafety Level Type (Biosafety Level 1, Biosafety Level 2, Biosafety Level 3, and Biosafety Level 4), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI107531

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Key Industry Developments: Mergers, Acquisitions, and Partnerships
    3. Epidemiology: Key Viral Diseases, By Key Countries, 2022
    4. Pipeline Analysis, By Key Players
    5. Impact of COVID-19 on the Market
  5. Global Viral Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    2. Market Analysis, Insights and Forecast – By Container Format
      1. Vials
      2. Prefilled Syringes
    3. Market Analysis, Insights and Forecast – By Biosafety Level Type
      1. Biosafety Level 1
      2. Biosafety Level 2
      3. Biosafety Level 3
      4. Biosafety Level 4
    4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Viral Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    2. Market Analysis, Insights and Forecast – By Container Format
      1. Vials
      2. Prefilled Syringes
    3. Market Analysis, Insights and Forecast – By Biosafety Level Type
      1. Biosafety Level 1
      2. Biosafety Level 2
      3. Biosafety Level 3
      4. Biosafety Level 4
    4. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Viral Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    2. Market Analysis, Insights and Forecast – By Container Format
      1. Vials
      2. Prefilled Syringes
    3. Market Analysis, Insights and Forecast – By Biosafety Level Type
      1. Biosafety Level 1
      2. Biosafety Level 2
      3. Biosafety Level 3
      4. Biosafety Level 4
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Viral Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    2. Market Analysis, Insights and Forecast – By Container Format
      1. Vials
      2. Prefilled Syringes
    3. Market Analysis, Insights and Forecast – By Biosafety Level Type
      1. Biosafety Level 1
      2. Biosafety Level 2
      3. Biosafety Level 3
      4. Biosafety Level 4
    4. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. South Korea
      6. Rest of Asia Pacific
  9. Rest of the World Viral Vaccines Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Form
      1. Liquid
      2. Lyophilized
    2. Market Analysis, Insights and Forecast – By Container Format
      1. Vials
      2. Prefilled Syringes
    3. Market Analysis, Insights and Forecast – By Biosafety Level Type
      1. Biosafety Level 1
      2. Biosafety Level 2
      3. Biosafety Level 3
      4. Biosafety Level 4
  10. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles
      1. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. GSK plc
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Sanofi
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. SEQIRUS (CSL Limited)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Moderna, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. AstraZeneca
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Novavax
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Dynavax Technologies
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Viral Vaccines Market Value Share (%), By Form, 2022 & 2030

Figure 2: Global Viral Vaccines Market Value Share (%), By Container Format, 2022 & 2030

Figure 3: Global Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2022 & 2030

Figure 4: Global Viral Vaccines Market Value Share (%), By Region, 2022 & 2030

Figure 5: North America Viral Vaccines Market Value (USD billion), by Form, 2022 & 2030

Figure 6: North America Viral Vaccines Market Value Share (%), by Form, 2022

Figure 7: North America Viral Vaccines Market Value (USD billion), by Container Format, 2022 & 2030

Figure 8: North America Viral Vaccines Market Value Share (%), by Container Format, 2022

Figure 9: North America Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2022 & 2030

Figure 10: North America Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2022

Figure 11: North America Viral Vaccines Market Value (USD billion), by Country, 2022 & 2030

Figure 12: North America Viral Vaccines Market Value Share (%), by Country, 2022

Figure 13: Europe Viral Vaccines Market Value (USD billion), by Form, 2022 & 2030

Figure 14: Europe Viral Vaccines Market Value Share (%), by Form, 2022

Figure 15: Europe Viral Vaccines Market Value (USD billion), by Container Format, 2022 & 2030

Figure 16: Europe Viral Vaccines Market Value Share (%), by Container Format, 2022

Figure 17: Europe Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2022 & 2030

Figure 18: Europe Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2022

Figure 19: Europe Viral Vaccines Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 20: Europe Viral Vaccines Market Value Share (%), by Country/ Sub-Region, 2022

Figure 21: Asia Pacific Viral Vaccines Market Value (USD billion), by Form, 2022 & 2030

Figure 22: Asia Pacific Viral Vaccines Market Value Share (%), by Form, 2022

Figure 23: Asia Pacific Viral Vaccines Market Value (USD billion), by Container Format, 2022 & 2030

Figure 24: Asia Pacific Viral Vaccines Market Value Share (%), by Container Format, 2022

Figure 25: Asia Pacific Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2022 & 2030

Figure 26: Asia Pacific Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2022

Figure 27: Asia Pacific Viral Vaccines Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 28: Asia Pacific Viral Vaccines Market Value Share (%), by Country/ Sub-Region, 2022

Figure 29: Rest of the World Viral Vaccines Market Value (USD billion), by Form, 2022 & 2030

Figure 30: Rest of the World Viral Vaccines Market Value Share (%), by Form, 2022

Figure 31: Rest of the World Viral Vaccines Market Value (USD billion), by Container Format, 2022 & 2030

Figure 32: Rest of the World Viral Vaccines Market Value Share (%), by Container Format, 2022

Figure 33: Rest of the World Viral Vaccines Market Value (USD billion), By Biosafety Level Type, 2022 & 2030

Figure 34: Rest of the World Viral Vaccines Market Value Share (%), By Biosafety Level Type, 2022

Figure 35: Global Viral Vaccines Market Share (%), By Company, 2022

Table 1: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2019-2030

Table 2: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2019-2030

Table 3: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2019–2030

Table 4: Global Viral Vaccines Market Revenue (USD billion) Forecast, By Region, 2019-2030

Table 5: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2019-2030

Table 6: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2019-2030

Table 7: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2019–2030

Table 8: North America Viral Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2030

Table 9: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2019-2030

Table 10: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2019-2030

Table 11: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2019–2030

Table 12: Europe Viral Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

Table 13: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2019-2030

Table 14: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2019-2030

Table 15: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2019–2030

Table 16: Asia Pacific Viral Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

Table 17: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Form, 2019-2030

Table 18: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Container Format, 2019-2030

Table 19: Rest of the World Viral Vaccines Market Revenue (USD billion) Forecast, By Biosafety Level Type, 2019–2030

Viral Vaccines Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 124
Consulting Services
    How will you benefit from our consulting services ?